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David Barford1, Yuichiro Takagi2, Patrick Schultz3,4 and Imre Berger5Most essential functions in eukaryotic cells are catalyzed by
complex molecular machines built of many subunits. To fully
understand their biological function in health and disease, it is
imperative to study these machines in their entirety. The
provision of many essential multiprotein complexes of higher
eukaryotes including humans, can be a considerable
challenge, as low abundance and heterogeneity often rule out
their extraction from native source material. The baculovirus
expression vector system (BEVS), specifically tailored for
multiprotein complex production, has proven itself to be
uniquely suited for overcoming this impeding bottleneck. Here
we highlight recent major achievements in multiprotein
complex structure research that were catalyzed by this
versatile recombinant complex expression tool.
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Introduction
Recombinant expression has had a profound impact on
protein research, and heterologous expression systems are
used on a daily basis in most molecular biology labora-
tories. The major workhorse for protein expression has
been Escherichia coli, and today a very large number of
expression plasmids and specialized strains, each with its
own merits, exist for this prokaryotic host. The over-
whelming majority of protein entries in the PBD (http://
www.rcsb.org/) originate from heterologous production in
E. coli. However, the increasing trend towards the studywww.sciencedirect.comof more complex biological assemblies, sometimes with
10 or more subunits, has necessitated the development of
more powerful eukaryotic expression systems that offer
access to multiprotein complexes, which for a variety of
reasons (large subunit size, requirement of post transla-
tional modifications and chaperones, others) cannot be
made efficiently in E. coli. The baculovirus expression
vector system (BEVS), introducedmore than 20 years ago,
has recently emerged as a particularly useful tool for
producing large eukaryotic protein complexes in the
quantity and quality required for detailed structural
study.
MultiBac: baculovirus expression vector
system for protein complex production
BEVS rely on a recombinant baculovirus carrying the
gene(s) of interest to infect insect cell cultures for
high-level heterologous production of the single protein
or protein complex of choice. BEVS has remained for
some time a relatively specialized application, but has
entered mainstream in structural biology laboratories in
the past several years. Engineering of the baculovirus
genome towards improved protein complex production
characteristics, the development of new plasmids and
stream-lined methods for multigene assembly and integ-
ration into the baculovirus genome, and the establish-
ment of standard operating procedures (SOPs) for cell
culture maintenance, virus generation, infection and
protein production have resulted in the MultiBac system,
a BEVS that is particularly easy-to-use and sufficiently
robust to be employed on a routine basis by users who do
not possess specialist training [1]. These are critically
important considerations for the use of BEVS in structural
biology laboratories, where the overriding objective is
protein sample preparation for structure analysis, and
the investment in optimizing individual expression
experiments necessarily needs to stay within a reasonably
short timeframe. MultiBac has been instrumental for
producing a number of multiprotein complexes that could
not be accessed before for structural and functional stu-
dies. Recent examples of such multiprotein complexes
are provided in the following, including the Head module
of the Mediator from Saccharomyces cerevisiae, the yeast
anaphase promoting complex APC/C, and the human
general transcription factor TFIID core complex, each
of which highlighting different aspects of BEVS appli-
cation that were exploited to achieve successful structure
determination.
The mediator head module from S. cerevisiae
Mediator is a large multiprotein complex that regulates
most, if not all, gene transcription by RNA polymerase IICurrent Opinion in Structural Biology 2013, 23:357–364
358 New constructs and expressions of proteins(Pol II) [2]. Mediator is structurally and functionally
conserved in all eukaryotes [3,4]. In the yeast S. cerevisiae,
where it was first discovered [5], Mediator comprises 21
subunits with a combined molecular mass exceeding
1 MDa [6,7]. Mediator functions as an interface between
DNA-bound protein activators of transcription and Pol II
[2,8,9]. Of medical relevance, the mutations on several
human Mediator subunits have been linked to neurologi-
cal disorders and cancers [10–16]. Thus, elucidation of the
molecular mechanisms of Mediator function is a major
research subject in biomedical sciences. Despite its para-
mount importance in gene regulation, the large size,
complexity, and low abundance of Mediator have made
biochemical and structural studies extremely difficult, if
not impossible, for a long time.
Single-particle electron microscopy (EM) provided first
impressions of the complexity underlyingMediator archi-
tecture. Unlike Pol II, which adopts a compact globular
structure, Mediator from yeast is composed of three
distinct modules [17,18], termed Head, Middle, and Tail
(Figure 1). As suggested by structural, genetic and bio-
chemical studies [19–21], the modules consist of 7–9
individual subunits each (Figure 1a). Mediator has
multiple activities [5], and each module is thought to
perform its own defined set of functions [22]. For
example, the subunits from the Head module genetically
interact with the C-terminal domain (CTD) of Pol II
[23,24], while several Middle and Tail module subunits
have been shown to directly interact with transcriptional
activators [9,21,25–27]. A reasonable strategy therefore is
to address particular Mediator functions by studying the
modules individually as first steps towards deciphering
the overall mechanism of the whole complex. While still a
formidable challenge, this approach certainly reduces the
otherwise intimidating complexity of studying Mediator
structure and function.
Producing the Mediator Head module in insect
cells
The Mediator Head module is composed of 7 subunits
(Med17, Med6, Med8, Med11, Med22, Med18, Med20)
with a molecular mass of 223 kDa. Originally, a conven-
tional co-infection approach with seven different bacu-
loviruses, each encoding for one subunit, was pursued
[28]. Highly expressing baculoviruses were carefully iso-
lated and optimized for maximum expression, and then
used in combination to co-infect insect cell cultures. This
procedure was exceedingly lengthy (each experiment
taking two months or more) and complicated logistics
as seven viruses had to be maintained at high titers
simultaneously in parallel. X-ray crystallography, how-
ever, requires rapid turnover of expression experiments.
Often, the production of a large number of variants of the
protein or complex studied is necessary, to identify the
sample which produces diffraction quality crystals, and
this must be within a timeframe that is as short as feasible.Current Opinion in Structural Biology 2013, 23:357–364The solution to this problem came by expressing all
Mediator Head subunits simultaneously from a single
multigene baculovirus using the MultiBac system,
thereby resolving a fundamental impediment. MultiBac
utilizes a procedure termed tandem recombineering (TR)
which considerably facilitates the iterative assembly of
multigene cassettes from small DNA progenitors [1]. All
genes encoding for theMediator Head subunits were thus
combined into a single construct by TR (Figure 1b)
[29,30], significantly reducing experimental complex-
ity. The multigene construct was next integrated into the
engineered MultiBac baculovirus genome that is charac-
terized by reduced proteolysis and delayed host cell lysis,
thus improving the quality of the sample produced [1].
The recombinant virus was used to infect insect cell
cultures to produce the Mediator Head (Figure 1b).
Crystal structure of recombinant Mediator
Head module
The simplified recombinant production propelled struc-
ture determination of the Head module by X-ray crystal-
lography. Modification of MED17 and MED18 by
eliminating flexible regions was critical to obtain well-
ordered single crystals suitable for diffraction data collec-
tion (Figure 1c). Incorporation of seleno-methionine in
the recombinantly produced sample was instrumental for
structure elucidation. The crystal structure of the
Mediator Head reveals how this essential complex is built
from its components combining stability as well as flexi-
bility for transcription regulation, providing a platform for
other transcription factors [30]. New features in the
structure provide first impressions about architectural
design principles of such large multiprotein machines.
Notably, a portion of the Head named ‘neck domain’
confers stability and integrity of the complex by forming a
novel multihelical bundle, engaging five of the seven
subunits of the Head simultaneously in one compact
structural unit (Figure 1c).
The anaphase promoting complex (APC/C)
The APC/C is an unusually large multisubunit RING E3
ubiquitin ligase that regulates cell cycle progression
through the proteasome-dependent proteolysis of cell
cycle regulatory proteins [31–33]. The core APC/C,
formed from at least 13 different proteins, is activated
on association of a regulatory coactivator subunit. The
APC/C is highly conserved across eukaryotes, and 12 of
the 13 S. cerevisiae APC/C subunits are conserved in
Saccharomyces pombe and human. Owing to the presence
of two copies of many APC/C proteins, the holo-APC/C is
comprised between 18 and 19 subunits with an overall
molecular mass ranging from 1 to 1.2 MDa [34].
Producing recombinant APC/C by BEVS:
co-infection with two viruses
Early research on the APC/C was restricted to the use
of native systems. Because most APC/C subunits arewww.sciencedirect.com
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S. cerevisae Mediator Complex. (a) Subunit organization of Mediator. Head module subunits are colored in blue; those of the Middle module are in
green and those of the Tail module are in ochre. (b) Genes encoding the Mediator Head module were assembled from multiple DNA progenitors (left)
into a single multigene expression construct (right, top) for insertion by Tn7 transposition (Tn7L, Tn7R) into the MultiBac baculovirus to produce the
Head module in infected insect cells (right, bottom). (c) X-ray crystal structure of the recombinant Mediator Head module showing Med17 (blue),
Med11 (purple), Med22 (green), Med6 (yellow), Med8 (red), Med18 (cyan), and Med 20 (orange). The Head consists of three distinct domains, fixed jaw,
movable jaw and neck (left). The neck domain is arranged in a novel multihelical bundle (right) [30].essential, genetic manipulations were intrinsically diffi-
cult, and the low natural abundance of APC/C limited
structural and biochemical studies. The recent develop-
ment of overexpression systems for S. cerevisiae andwww.sciencedirect.comhuman APC/C [34,35], based on the MultiBac BEVS
that reconstitutes all APC/C proteins, now enables a range
of structural, biochemical and biophysical investigations.
The expression and reconstitution of recombinantCurrent Opinion in Structural Biology 2013, 23:357–364
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Structures of the APC/C and MCC. 3-D EM reconstructions of (a) recombinant S. cerevisiae APC/C and (b) endogenous S. cerevisiae APC/C. (c)
Localisation of the Cdc16 dimer in Cdc16-assigned density (mesh). (d) Pseudo atomic structure of S. cerevisiae APC/C, adapted from [34]. (e)
Endogenous human APC/C [51]. (f) Recombinant human APC/C [35]. (g) Structure of the S. pombe mitotic checkpoint complex [50].S. cerevisiae APC/C [34] used the first generation Multi-
Bac cloning system for insect cell-baculovirus expression
[36–41]. To express S. cerevisiae APC/C, two viruses
encoding five and eight subunits were combined for
co-expression. The resultant recombinant co-expression
system yielded 200-fold more intact APC/C than the
endogenous system (0.5 mg/L insect cell culture). The
reconstituted S. cerevisiaeAPC/Cwas correctly assembled,
as judged by its structural correspondence to native APC/
C (Figure 2a and b), and its capacity to ubiquitinate
mitotic cyclin in the presence of coactivator in a D box
and KEN box dependent manner [34]. The ability to
recapitulate the endogenous APC/C catalytic and regu-
latory activity using recombinant reconstituted APC/C
provided strong evidence that the molecular composition
of S. cerevisiae APC/C had been completely defined, a
crucial prerequisite for understanding the complete sys-
tem.
Dissecting recombinant yeast APC/C
Reconstitution of the holo-APC/C and APC/C subcom-
plexes allowed an accurate determination of the APC/C
mass. An APC/C subcomplex of eight subunits was ana-
lyzed using native mass spectrometry and measured as
698.8 kDa, in good agreement with that predicted for a
complex containing all subunits in unit stoichiometry plus
an additional copy of Cdc23 [34]. Generation of APC/CCurrent Opinion in Structural Biology 2013, 23:357–364subcomplexes, guided by an architectural map of the
APC/C [42], and subsequent determination of their
EM structures allowed the assignment of the three-
dimensional molecular boundaries of individual subunits
within the APC/C molecular envelope. As an example,
comparing two APC/C subcomplexes differing by Cdc16–
Cdc26 indicated difference density that corresponded
closely to the crystal structure of the Cdc16–Cdc26 het-
erotetramer (Figure 2c) [43]. This subunit deletion
approach allowed a systematic assignment of the majority
of large APC/C subunits and by integrating crystal struc-
tures, and homology models of individual APC/C sub-
units, with a cryo-EM reconstruction of an APC/CCdh1D-
box ternary complex at 10 A˚ resolution [44], a high-resol-
ution description of the subunit organization and pseudo-
atomic model of the APC/C was determined (Figure 2d)
[34,44]. The approach of subunit deletion employed by
[34] accurately defines the molecular boundaries of
specific APC/C subunits, enabling more reliable docking
of subunit atomic models compared with that possible
from the approximate locations of subunits defined by
labeling N-termini and C-termini.
BEVS expression of complete human APC/C
More recently the overexpression and reconstitution of
human APC/C in the insect/baculovirus system were
reported by two groups [35,45]. One group generatedwww.sciencedirect.com
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pFBDM and pUCDM vectors [36], using USER ligation-
independent cloning methods [46,47] and incorporated
all 14 genes (45 kb) into two baculoviruses [35], whereas
the second group generated 14 individual viruses, each
expressing a single APC/C subunit, which were combined
for co-expression in insect cells for biochemical studies
[45]. Interestingly Apc15 and Apc16 were only recently
discovered as human APC/C subunits. Efforts to generate
fully assembled recombinant human APC/C before the
identification of Apc16 were unsuccessful [35]. This
indicated that Apc16, located within the TPR subcom-
plex [48], is necessary for the optimal assembly of recom-
binant human APC/C in insect cells. Thus, the successful
assembly and reconstitution of human APC/C using the
insect cell/baculovirus expression system indicated that
all human APC/C subunits necessary for a functional and
catalytically active APC/C had finally been identified
(Figure 2e and f).
X-ray structure of the mitotic checkpoint
complex (MCC), a regulator of APC/C
To ensure correct chromosome segregation in mitosis, the
spindle assembly checkpoint imposed by the MCC inhi-
bits the APC/C until all chromosomes have achieved
correct bipolar attachment to the mitotic spindle [49].
The MCC comprises the APC/C coactivator Cdc20
associated with the checkpoint proteins Mad2, Mad3/
BubR1 and Bub3 and blocks D box and KEN box
recognition by the APC/C. The crystal structure of S.
pombe MCC (without Bub3) expressed using the Multi-
Bac system revealed that Cdc20, Mad2 and Mad3 assem-
ble into a triangular-shaped heterotrimer (Figure 2g)
[50]. Mad3 coordinates the overall organization of the
complex by forming numerous inter-subunit interactions
with Mad2 and Cdc20. A helix-loop-helix motif at the N-
terminus of Mad3 binds simultaneously to Mad2 and
Cdc20, orienting the KEN box that acts as a pseudo-
substrate inhibitor towards its receptor on Cdc20.
Human general transcription factor TFIID
Initiation of transcription by RNA polymerase II (Pol II)
requires the controlled step-wise assembly of the pre-
initiation complex (PIC), comprising a large ensemble of
proteins and protein complexes including Pol II and the
general transcription factors GTFs (TFIIA, B, D, E, F, H)
[52–54]. The promoter recognition complex, TFIID, is
thought to be the cornerstone of PIC assembly. In
addition, TFIID functions as a coactivator, mediating
signals from sequence-specific activators to other com-
ponents of the transcription machinery. In humans,
TFIID comprises 14 protein subunits, TBP and the
TBP associated factors (TAFs), ranging in size from
250 kDa to less than 20 kDa, with a multitude of func-
tions [52,53]. TAFs and TBP assemble into a large multi-
subunit complex with around 20 subunits and an overall
molecular weight of 1.6 MDa [54].www.sciencedirect.comOur understanding of TFIID and its crucial role in
transcription regulation is considerably hampered by a
lack of detailed knowledge of the molecular architecture
of this essential factor, its assembly in the cell, and its
interactions with chromatin and other factors in the con-
text of activated transcription. The overall shape of
human and yeast TFIID was shown by EM, revealing
an asymmetric tri-lobed structure resembling a molecular
clamp [54]. The paucity and heterogeneity of the
endogenous material used in these studies have limited
structural insight to moderate resolution (30–40 A˚ for
human TFIID), prohibiting molecular level interpret-
ation of TFIID architecture notwithstanding consider-
able effort.
The current consensus regarding the copy-number of
subunits within TFIID is that a subset of TAFs exists
in two copies, while TBP and the remaining TAFs are
present in single copy [52]. Owing to evolutionary con-
servation and overall similarity in shape of the yeast and
human TFIID complexes, this subunit composition is
probably to be present in TFIID from most species. The
concept emerged in which TAFs present in duplicate
form a putative, 2-fold symmetric scaffold, around which
the remaining TAFs and TBP organize as peripheral
subunits [52], suggesting that a transition from symmetry
to asymmetry may occur in the TFIID assembly pathway.
Compelling functional support for this bipartite architec-
tural design came from studies in Drosophila cells [55]. By
means of RNAi to knockdown specific TAFs, a stable and
functional core-TFIID complex, composed of TAF4, 5, 6,
9 and 12, was revealed in vivo. Further support stems from
cryo-EM studies of TFIID preparations from yeast, in
which a quasi-symmetric smaller shape was also found
[56]. Together, these results point to the existence of a
symmetric core-TFIID module of pivotal importance for
the integrity and assembly of holo-TFIID.
Expressing human TFIID core complex:
polyproteins adjust stoichiometries
The architecture of the human TFIID core complex,
consisting of 10 subunits (two copies each of TAF4, 5, 6, 9
and 12), was recently elucidated at nanometer resolution
by an integrated approach combining recombinant over-
production by MultiBac, cryo-EM, data from X-ray crys-
tallography and homology models [57] (Figure 3). The
structure revealed a symmetric arrangement of the sub-
units, validating previous experiments. Initially, the
TFIID core complex was produced by using a single
baculovirus containing the encoding genes arranged as a
multigene construct made up of individual expression
cassettes [36], similar to the strategy adopted for the
successful study of the Mediator Head module from S.
cerevisiae [30]. In the case of core-TFIID, however, it
turned out that the expression levels of the individual
subunits varied substantially, thus reducing overall yield
of the recombinant complex dramatically. Large amountsCurrent Opinion in Structural Biology 2013, 23:357–364
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Figure 3
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Human general transcription factor TFIID core complex. (a) Generally applicable polyprotein strategy for balancing the production levels of multiprotein
complex subunits. Genes of interest (GOI), a protease encoding gene (TEV NIa) and a fluorescent marker (CFP) are present in a single ORF under
control of a strong baculoviral promoter (polh) and flanked by a poly A signal (black square) on a MultiBac plasmid (cf. Figure 1B), spaced apart by the
specific cleavage sequence of TEV NIa (tcs) [1,58]. (b) Polyprotein expression and purification of human core-TFIID. Negative stain EM and 2-D
classification (bottom, right) were used to optimize purification until high-quality sample was obtained as demonstrated by SDS-PAGE (bottom, left). (c)
TFIID core complex structure at nanometer resolution, determined by hybrid methods [57].of heterologous protein was produced in excess while the
subunit characterized by the lowest expression level
relative to the others dictated the final amount of properly
assembled complex containing all subunits. A rescue
strategy involving tagging of this weakly expressing sub-
unit with an affinity tag did result in the purification of
complete core-TFIID, however, EM analysis revealed
the presence of smaller subassemblies lacking subunits
that were contaminating the sample, impeding structure
determination.
This challenge was resolved by adopting a strategy that
certain viruses such as Coronavirus use to realize their
proteome [41] (Figure 3A). These viruses express long
open-reading frames (ORFs) that are translated into large
polyproteins. These polyproteins are then processed into
individual proteins by a highly specific protease that cuts
proteolytic sites in between the functional polypeptide
entities. Typically, the protease is also part of the poly-
protein, and liberates itself as well bymeans of proteolytic
cleavage. This strategy was implemented in theMultiBac
system by creating long single ORFs composed of the
TAF genes. The gene encoding for NIa protease from
Tobacco etch virus (TEV) was added at the 50, and
corresponding recognition and cleavage sequences were
inserted [1,41]. To follow and quantify polyprotein pro-
duction during expression, the gene encoding for a fluor-
escent protein was appended to the 30 end of the ORFCurrent Opinion in Structural Biology 2013, 23:357–364(Figure 3a). The TEV NIa protease proved to be suffi-
ciently specific to process the polyproteins expressed
properly and to completion. This resulted in a fully
balanced level of the TAF proteins resulting from poly-
protein processing that assembled completely into the
TFIID core complex. Core-TFIID was purified to hom-
ogeneity, enabling high-resolution structure determi-
nation (Figure 3b and c). Expression of two further
TAFs, TAF8 and TAF10, likewise from a polyprotein
construction, and incorporation into the core-TFIID com-
plex followed by cryo-EM structure determination,
allowed to propose a molecular mechanisms of TFIID
rearrangement during assembly when the symmetric core
accretes further TAFs and TBP, giving rise to the com-
plete holo-complex that is asymmetric [57].
Conclusions
Methodologies such as protein crystallography require
large quantities of highly concentrated homogeneous
sample to obtain high-resolution structural information.
EM and single particle analysis methods do not require
such high concentrations or total amounts of sample, but
do still require high sample homogeneity, reasonable
particle density on EM micrographs and optimal EM
grid preparations. Native mass spectrometry that allows
determination of subunit stoichiometry and insights into
multimeric complex assembly processes is also depend-
ent on highly concentrated, high quality sample inwww.sciencedirect.com
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mens are likewise required for functional studies and for
pharmaceutical applications. Recombinant expression
enables to exactly specify the subunit composition of
multiprotein complexes, thus increasing homogeneity.
Further, engineering and mutating specific subunits offer
the potential to test biological hypotheses, including
examining the roles and locations of specific subunits
within the context of the whole complex, which is a vital
prerequisite for understanding biological function.
Most essential processes in cells are carried out by large
multiprotein machines, and many of these are critically
dependent on recombinant expression for analyzing their
structure and function in detail. Eukaryotic complexes
will in many cases require eukaryotic expression systems
for their provision in the quality and quantity required.
Remarkable advances in eukaryotic expression technol-
ogies that can provide these specimens are being made,
with new and powerful systems being put at the disposal
of the community. We anticipate that new expression
tools including those described here will prove to be
instrumental for the detailed study of many important
protein complexes that have remained elusive to date.
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